Table 1.
Patient characteristics.
| Characteristic | Factor | Number (%)/Mean (SD) | Range |
|---|---|---|---|
| Sex | Female | 10 (11.8%) | |
| Male | 75 (88.2%) | ||
| Age (years) | 64.3 (9.8) | 45–83 | |
| BMI | 26.79 (4.01) | 16–40 | |
| Surgical technique | Open | 8 (9.4%) | |
| Laparoscopic | 51 (60%) | ||
| Hybrid | 13 (15.3%) | ||
| Robotic | 13 (15.3%) | ||
| UICC stage (missing information in n = 3 patients) | I | 7 (8.2%) | |
| II | 18 (21.2%) | ||
| III | 49 (57.6%) | ||
| IV | 8 (9.4%) | ||
| Neoadjuvant chemotherapy | No | 0 (0.0%) | |
| Yes | 85 (100.0%) | ||
| Neoadjuvant chemoradiotherapy | No | 67 (78.8%) | |
| Yes | 18 (21.2%) | ||
| Complications (overall) | No | 24 (28.2%) | |
| Yes | 61 (71.8%) | ||
| Major complications | No | 40 (47.1%) | |
| Yes | 45 (52.9%) | ||
| Anastomotic leakage | No | 74 (87.1%) | |
| Yes | 11 (12.9%) | ||
| Pneumonia | No | 58 (68.2%) | |
| Yes | 27 (31.8%) | ||
| Hospitalization (d) | 27.75 (38.75) | 10–261 | |
| DFS (months) | 11.51 (13.01) | 0–61 | |
| OS | 14.38 (13.75) | 1–61 | |
| VAT (cm2) | 156.37 (89.95) | 6.62–399.70 | |
| SAT (cm2) | 166.25 (71.59) | 14.00–393.30 | |
| ATR | 0.977 (0.516) | 0.04–2.44 | |
| PMA (cm2) | 19.89 (5.50) | 9.92–37.96 | |
| PMV | 183.75 (59.87) | 67.04–346.91 | |
| TAMA (cm2) | 147.98 (30.26) | 78.40–228.13 | |
| LSMI (cm2/m2) | 47.44 (7.91) | 30.63–68.42 | |
| Sarcopenia | No | 27 (31.8%) | |
| Yes | 58 (68.2%) | ||
| Sarcopenic obesity | No | 78 (91.8%) | |
| Yes | 7 (8.2%) |